SCHEMBL16238985

SCHEMBL16238985

Nc1cc(C(F)(F)F)ccc1Nc1ccc(NS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.68
ALDH1A1 P00352 2/20 0.68
KMT2A Q03164 2/20 0.68
KDM4E B2RXH2 1/20 0.68
GAA P10253 1/20 0.68
MAPT P10636 1/20 0.68
GFER P55789 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
FFAR4 Q5NUL3 3/20 0.57
NR1H3 Q13133 1/20 0.53
AR P10275 2/20 0.53
NR3C1 P04150 1/20 0.53
PGR P06401 1/20 0.53
ESR2 Q92731 1/20 0.53
IDH2 P48735 1/20 0.53
KEAP1 Q14145 2/20 0.51
GPR27 Q9NS67 5/20 0.50
AVPR2 P30518 4/20 0.50
PPARG P37231 1/20 0.50
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1138972 0.87 MEN1 (0.57) MEN1ALDH1A1KMT2AKDM4EGAA
SCHEMBL2567685 0.81 NR1H3 (0.71) MEN1ALDH1A1KMT2AMAPTFFAR4
SCHEMBL31301150 0.81 KEAP1 (0.55) MEN1ALDH1A1KMT2AFFAR4PGR
SCHEMBL16238966 0.81 KEAP1 (0.55) MEN1ALDH1A1KMT2AFFAR4PGR
SCHEMBL16239045 0.81 KEAP1 (0.55) MEN1ALDH1A1KMT2AGAAMAPT
SCHEMBL11390047 0.79 ALDH1A1 (0.81) MEN1ALDH1A1KMT2AKDM4EGAA
SCHEMBL15646797 0.78 KMT2A (0.58) MEN1ALDH1A1KMT2AKDM4EGAA
SCHEMBL6657103 0.77 GAA (0.72) MEN1ALDH1A1KMT2AKDM4EGAA
SCHEMBL6976724 0.75 PPARG (0.57) MAPTFFAR4NR1H3ARNR3C1
Hydrochloric Acid SCHEMBL10529934 0.75 ALDH1A1 (0.73) MEN1ALDH1A1KMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240417379-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2024-12-19 US disclosed
US-12116351-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD (JP) 2024-10-15 US disclosed
US-20220380322-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2022-12-01 US disclosed
US-11434207-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD (JP) 2022-09-06 US disclosed
CN-108863959-B P2X4 receptor antagonists 日本化学药品株式会社 2021-11-30 CN disclosed
US-20200223806-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2020-07-16 US disclosed
CN-111333588-A P2X4 receptor antagonists 日本化学药品株式会社 2020-06-26 CN disclosed
US-10633349-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD (JP) 2020-04-28 US disclosed
CN-104066724-B P2X4 receptor antagonists 日本化学药品株式会社 2020-04-17 CN disclosed
CN-110483423-A P2X4 receptor antagonist NIPPON CHEMIPHAR CO 2019-11-22 CN disclosed
CN-108863959-A P2X4 RECEPTOR ANTAGONIST 日本化学药品株式会社 2018-11-23 CN disclosed
US-20180201587-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2018-07-19 US disclosed
US-9969700-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD. (JP) 2018-05-15 US disclosed
EP-2803662-B1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO (JP) 2017-03-01 EP disclosed
US-20160280667-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2016-09-29 US disclosed
US-9382236-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD (JP) 2016-07-05 US disclosed
US-20140357858-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2014-12-04 US disclosed
EP-2803662-A1 P2X4 RECEPTOR ANTAGONIST Nippon Chemiphar Co., Ltd. (JP) 2014-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220380322-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 MEN1 3450/4885ALDH1A1 3019/4885KMT2A 2174/4885
US-20240417379-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 MEN1 3285/4885ALDH1A1 3045/4885KMT2A 2558/4885
US-12116351-B2 P2X4 receptor antagonist P2RX7, P2RX1, P2RX2 MEN1 3450/4885ALDH1A1 3019/4885KMT2A 2174/4885
US-20160280667-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 MEN1 3353/4885ALDH1A1 3013/4885KMT2A 2156/4885
US-20140357858-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 MEN1 3450/4885ALDH1A1 3019/4885KMT2A 2174/4885
US-20200223806-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 MEN1 3450/4885ALDH1A1 3019/4885KMT2A 2174/4885
US-11434207-B2 P2X4 receptor antagonist P2RX7, P2RX1, P2RX2 MEN1 3450/4885ALDH1A1 3019/4885KMT2A 2174/4885
US-10633349-B2 P2X4 receptor antagonist P2RX7, P2RX1, P2RX2 MEN1 3450/4885ALDH1A1 3019/4885KMT2A 2174/4885
US-20180201587-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 MEN1 3450/4885ALDH1A1 3019/4885KMT2A 2174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.